0
Signin
countryflagUS

18889881171

AAPL 212.78 -1.1429% MSFT 386.0 -0.4693% NVDA 118.159 0.5437% GOOGL 162.26 -0.9946% GOOG 164.29 -1.1968% AMZN 194.215 -0.6776% META 590.9 1.1711% AVGO 189.5096 -3.0988% LLY 839.62 0.3118% TSLA 233.08 -1.1787% TSM 177.34 2.0603% V 339.53 -0.1% JPM 239.365 0.1066% UNH 510.88 1.5262% NVO 78.63 -0.4684% WMT 85.915 -0.4807% LVMUY 130.5 -2.1152% XOM 115.85 0.3812% LVMHF 655.0 -2.1687% MA 536.55 0.0858%
AAPL 212.78 -1.1429% MSFT 386.0 -0.4693% NVDA 118.159 0.5437% GOOGL 162.26 -0.9946% GOOG 164.29 -1.1968% AMZN 194.215 -0.6776% META 590.9 1.1711% AVGO 189.5096 -3.0988% LLY 839.62 0.3118% TSLA 233.08 -1.1787% TSM 177.34 2.0603% V 339.53 -0.1% JPM 239.365 0.1066% UNH 510.88 1.5262% NVO 78.63 -0.4684% WMT 85.915 -0.4807% LVMUY 130.5 -2.1152% XOM 115.85 0.3812% LVMHF 655.0 -2.1687% MA 536.55 0.0858%

mid-cap

Technical Analysis on One NASDAQ- Listed Biotechnology Stock- OCEA

Mar 17, 2025 | Team Kalkine
Technical Analysis on One NASDAQ- Listed Biotechnology Stock- OCEA
Image source: shutterstock

OCEA:NASDAQ
Investment Type
Mid - Cap
Risk Level
Action
Rec. Price (US$)

Ocean Biomedical, Inc. (NASDAQ: OCEA)

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a biopharmaceutical company. The Company is focused on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation.

Technical Observation (on the daily chart): 

Xxxxxx Xxxxxx Xxxxxx

Xxxxxx Xxxxxx

Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .

Xxxxxx Xxxxxx Xxxxxx Xxxxxx & Xxxxxx

  • Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx
  • Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .

Xxxxxx Xxxxxx

Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .

Xxxxxx

Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .   

Interested?

Enter your details below and our team will help you to decide if this product is best for you.
  • Australia+61
  • Canada+1
  • India (भारत)+91
  • New Zealand+64
  • United Kingdom+44
  • United States+1
By submitting my details and clicking on the button below, I agree to Kalkine’s Terms and Conditions and Privacy Policy.
I agree to receive marketing calls from Kalkine on the phone number I have provided above. I understand and agree that these calls may be placed using an auto-dialer and that my consent is not a condition of any purchase.
Please wait processing your request...
Disclaimer-

Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions  and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.

Mid-Cap
Watch Out for One NASDAQ- Listed Medical Equipment Stock - Applied DNA Sciences Inc
Mar 20, 2025 Team Kalkine
Blue-Chip
One NYSE Listed Gold Mining Stock at Resistance Level: Franco-Nevada Corporation
Mar 20, 2025 Team Kalkine
Small-Cap
Watch Out for One NASDAQ- Listed Medical Equipment Stock - Applied DNA Sciences Inc
Mar 20, 2025 Team Kalkine
Small-Cap
Technical Analysis on One NYSE- Listed Diversified Mining Stock- FSM
Mar 20, 2025 Team Kalkine
Small-Cap
One NASDAQ- Listed Biotechnology Stock at Resistance Level: PBYI
Mar 20, 2025 Team Kalkine